GLP-1 receptor agonists are medications designed to mimic the effects of glucagon-like peptide-1, a hormone involved in blood sugar regulation and appetite control. By binding to GLP-1 receptors in the pancreas and brain, these medications enhance insulin secretion, suppress glucagon production, and slow gastric emptying. This multifaceted mechanism contributes to better blood sugar management and reduced hunger.